AFT Pharmaceuticals Future Growth
Future criteria checks 4/6
AFT Pharmaceuticals is forecast to grow earnings and revenue by 23.6% and 12.4% per annum respectively. EPS is expected to grow by 24.8% per annum. Return on equity is forecast to be 17.9% in 3 years.
Key information
23.6%
Earnings growth rate
24.8%
EPS growth rate
| Pharmaceuticals earnings growth | 47.8% |
| Revenue growth rate | 12.4% |
| Future return on equity | 17.9% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 295 | 26 | 25 | 14 | 3 |
| 3/31/2026 | 264 | 23 | 17 | 12 | 3 |
| 3/31/2025 | 223 | 15 | 12 | 11 | 3 |
| 9/30/2024 | 199 | 12 | 17 | 26 | N/A |
| 6/30/2024 | 197 | 14 | 18 | 27 | N/A |
| 3/31/2024 | 195 | 16 | 19 | 29 | N/A |
| 12/31/2023 | 185 | 13 | 12 | 21 | N/A |
| 9/30/2023 | 175 | 11 | 4 | 13 | N/A |
| 6/30/2023 | 166 | 11 | 3 | 12 | N/A |
| 3/31/2023 | 157 | 11 | 2 | 12 | N/A |
| 12/31/2022 | 149 | 14 | 4 | 12 | N/A |
| 9/30/2022 | 141 | 17 | 6 | 13 | N/A |
| 6/30/2022 | 135 | 18 | 7 | 14 | N/A |
| 3/31/2022 | 130 | 20 | 9 | 14 | N/A |
| 12/31/2021 | 125 | 15 | 7 | 12 | N/A |
| 9/30/2021 | 120 | 11 | 5 | 10 | N/A |
| 6/30/2021 | 116 | 9 | 0 | 6 | N/A |
| 3/31/2021 | 113 | 8 | -5 | 1 | N/A |
| 12/31/2020 | 110 | 5 | -4 | 3 | N/A |
| 9/30/2020 | 107 | 3 | -2 | 6 | N/A |
| 6/30/2020 | 107 | 7 | 3 | 10 | N/A |
| 3/31/2020 | 106 | 12 | 8 | 15 | N/A |
| 12/31/2019 | 100 | 11 | 7 | 12 | N/A |
| 9/30/2019 | 94 | 11 | 5 | 9 | N/A |
| 6/30/2019 | 89 | 4 | 1 | 5 | N/A |
| 3/31/2019 | 85 | -3 | -2 | 1 | N/A |
| 12/31/2018 | 84 | -7 | -5 | -1 | N/A |
| 9/30/2018 | 83 | -11 | -8 | -4 | N/A |
| 6/30/2018 | 82 | -12 | N/A | -6 | N/A |
| 3/31/2018 | 81 | -14 | N/A | -9 | N/A |
| 12/31/2017 | 79 | -14 | N/A | -13 | N/A |
| 9/30/2017 | 76 | -14 | N/A | -16 | N/A |
| 6/30/2017 | 73 | -16 | N/A | -18 | N/A |
| 3/31/2017 | 69 | -18 | N/A | -19 | N/A |
| 12/31/2016 | 67 | -18 | N/A | -20 | N/A |
| 9/30/2016 | 64 | -18 | N/A | -21 | N/A |
| 6/30/2016 | 64 | -16 | N/A | -17 | N/A |
| 3/31/2016 | 64 | -13 | N/A | -14 | N/A |
| 12/31/2015 | 63 | -13 | N/A | -12 | N/A |
| 9/30/2015 | 62 | -13 | N/A | -10 | N/A |
| 6/30/2015 | 59 | -13 | N/A | -11 | N/A |
| 3/31/2015 | 56 | -13 | N/A | -13 | N/A |
| 3/31/2014 | 49 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AFP's forecast earnings growth (23.6% per year) is above the savings rate (2.6%).
Earnings vs Market: AFP's earnings (23.6% per year) are forecast to grow faster than the Australian market (12.4% per year).
High Growth Earnings: AFP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AFP's revenue (12.4% per year) is forecast to grow faster than the Australian market (5.7% per year).
High Growth Revenue: AFP's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AFP's Return on Equity is forecast to be low in 3 years time (17.9%).